Basement of matrix therapy in regenerative medicine by RGTA® : From fundamental to plastic surgery

被引:7
|
作者
Barritault, D. [2 ,3 ]
Garcia-Filipe, S. [2 ]
Zakine, G. [1 ]
机构
[1] CHRU Tours, Hop Trousseau, Ctr Brules, Serv Chirurg Plast Reconstructrice & Esthet, F-37044 Tours, France
[2] Univ Paris Est, Lab CRRET CNRS EAC 7149, F-94000 Creteil, France
[3] Soc OTR3, F-75001 Paris, France
来源
关键词
ReGeneraTing Agents or RGTA (R); Fibrosis; Scar; Cutaneous regeneration; CACIPLIQ20 (R);
D O I
10.1016/j.anplas.2010.09.002
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cells present continuous renewal, permitting permanent regeneration which is called tissue homeostasis. The signaling protein, known as growth factors, cytokines, interleukins and chemokines, but also the extracellular matrix play a key role in the cellular communication. All processes are deregulated after tissue injury, inducing scars. By reconstituting the extracellular matrix, it is possible to avoid the development of scar and to favorize the regeneration of the injured tissue. Glycosaminoglycans, and particularly heparan sulfates, by participating to the extracellular matrix structure, are implicated in cellular communication. This article describes how, by creating heparan sulfate mimetic or Regenerating Agent (RGTA), a French academic team has demonstrated that mammals have the ability to regenerate, by restoring the proper cellular micro-environment. After a first clinical development in two severe and chronic pathologies (corneal and skin ulcers), we show now the potential of these agents in plastic and reconstructive surgery, to regulate fibrosis and to enhance speed and quality of tissue healing. (C) 2010 Published by Elsevier Masson SAS.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 50 条
  • [1] RGTA®-based matrix therapy - A new branch of regenerative medicine in locomotion
    Barritault, Denis
    Desgranges, Pascal
    Meddahi-Pelle, Anne
    Denoix, Jean-Marie
    Saffar, Jean-Louis
    JOINT BONE SPINE, 2017, 84 (03) : 283 - 292
  • [3] New clinical development of RGTA based Matrix therapy technology in regenerative medicine.
    Barritault, Denis
    WOUND REPAIR AND REGENERATION, 2022, 30 (05) : A7 - A7
  • [4] Regenerative medicine and plastic surgery
    Machens, HG
    Mailänder, R
    CHIRURG, 2005, 76 (05): : 474 - 480
  • [5] Regenerative Medicine and the Future of Plastic Surgery
    D'Amico, Richard A.
    Rubin, J. Peter
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 133 (06) : 1511 - 1512
  • [6] Regenerative therapy approaches in plastic surgery
    Kuhbier, J. W.
    Reimers, K.
    Radtke, C.
    Vogt, P. M.
    CHIRURG, 2015, 86 (03): : 214 - 222
  • [7] Regenerative medicine and plastic surgery [Regenerative medizin und plastische chirurgie]
    Machens H.-G.
    Mailänder P.
    Der Chirurg, 2005, 76 (5): : 474 - 480
  • [8] Regenerative Medicine in Facial Plastic and Reconstructive Surgery A Review
    Miller, Matthew Q.
    Dighe, Abhijit
    Cui, Quanjun
    Park, Stephen S.
    Christophel, J. Jared
    JAMA FACIAL PLASTIC SURGERY, 2016, 18 (05) : 391 - 394
  • [9] Plastic Surgery Challenges in War Wounded II: Regenerative Medicine
    Valerio, Ian L.
    Sabino, Jennifer M.
    Dearth, Christopher L.
    ADVANCES IN WOUND CARE, 2016, 5 (09) : 412 - 419
  • [10] RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients
    Denis Barritault
    Marie Gilbert-Sirieix
    Kim Lee Rice
    Fernando Siñeriz
    Dulce Papy-Garcia
    Christophe Baudouin
    Pascal Desgranges
    Gilbert Zakine
    Jean-Louis Saffar
    Johan van Neck
    Glycoconjugate Journal, 2017, 34 : 325 - 338